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Abstract The aim of this study was to examine the in vivo
effect of growth hormone (GH) on cell proliferation and
apoptosis and on the gene expression of selected proteins in
the chicken oviduct before sexual maturity (first oviposition).
Ten-week-old Hy-Line Brown chickens were injected three
times a week with 200 μg·kg-1 body weight of recombinant
chicken GH (cGH) until 16 weeks of age. Control hens
received 0.9 % NaCl with 0.05 % bovine serum albumin as
a vehicle. Treatment with cGH increased (P<0.05) oviduct
weight at 16 weeks of age, i.e. 1–2 weeks before onset of egg
laying. The highest number of proliferating (determined by
proliferating cell nuclear antigen [PCNA] immunocytochem-
istry) and apoptotic (determined by TUNEL assay) cells in the
oviduct was found in the mucosal epithelium, and the lowest
in the stroma. Administration of cGH did not increase
(P>0.05) the number of PCNA-positive cells but it decreased
(P<0.01) the number of TUNEL-positive cells, thus increas-
ing the proliferating-to-apoptotic cell ratio in the oviduct.
Gene expression (determined by real-time polymerase chain
reaction) of apoptosis-related caspase-2 in the magnum and
caspase-3 in the magnum and isthmus and their activity (de-
termined by fluorometric assay) in the magnum were attenu-
ated (P<0.05) in cGH-treated hens. The gene expression of
the magnum-specific ovalbumin and the shell-gland-specific
ovocalyxins 32 and 36 was increased (P<0.05) in cGH-
treated chickens. In contrast, the expression of Bcl-2 and of
caspases 8 and 9 was not affected by cGH in any of the
oviductal segments. The results suggest that GH, via the
orchestration of apoptosis and expression of some oviduct-
specific proteins, participates in the development and activity
of the chicken oviduct prior to the onset of egg laying.
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Introduction
The hen oviduct is of special interest to commercial egg
producers because disrupted activity or pathological changes
directly affect egg quality and ultimately decrease economic
profitability (Chousalkar and Roberts 2008). Moreover, in
biotechnological applications, the use of chicken oviduct as
a bioreactor for the production of human therapeutic proteins
has garnered interest. The avian oviduct is divided morpho-
logically and functionally into five regions. The infundibulum
engulfs the ovum, which is released upon ovulation; this is
where fertilization takes place and the first layer of egg white
is secreted. The magnum produces most (∼15 g) of the egg
white. Both inner and outer shell membranes are formed in the
isthmus. Calcification of the eggshell and its subsequent pig-
mentation and cuticle deposition occur in the shell gland.
When these processes are complete, expulsion of the egg
through the vagina begins.
The avian oviduct undergoes dynamic morphological and
functional changes during the reproductive cycle. The most
important processes involved in avian oviduct development
and function seem to be cell proliferation, differentiation and
apoptosis. Apoptosis allows the controlled removal of aged,
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damaged, infected or unwanted cells, maintaining homeosta-
sis and remodelling in multicellular organisms. The control of
cell death is dependent on competing pro- and anti-apoptotic
signals (Elmore 2007; Hawkins and Devitt 2013; McIlwain
et al. 2013). Among these are proteins from the Bcl-2 family,
survivin, an inhibitor of T-cell apoptosis (Ita) and the
apoptosis-inducing factor FasL. The Bcl-2 family consists of
not only proteins that inhibit apoptosis, but also proteins that
stimulate it (Watters and Lavin 1999). For instance, the over-
expression of Bcl-2 inhibits apoptosis (Allen et al. 1998). The
caspases, i.e. intracellular proteases whose activation leads to
the cleavage of numerous cellular proteins, play specific roles
in apoptosis. In general, two main apoptotic pathways can be
found: extrinsic and intrinsic. Each of these activates its own
initiator caspases, such as caspases 1, 2, 8, 9 and 10, which in
turn activate executioner caspases (caspases 3, 6 and 7),
resulting in cell death. Caspase-3 is considered to be the most
important of the executioner caspases and is activated by any
of the initiator caspases (Hengartner 2000; Elmore 2007;
McIlwain et al. 2013).
The control of oviduct development and activity is mainly
orchestrated by ovarian steroids. Oestrogens are the key ste-
roids controlling oviductal growth and activity, via the regu-
lation of cell proliferation and differentiation, and the synthe-
sis of egg proteins (Dougherty and Sanders 2005). Ni et al.
(2007) have found the growth hormone (GH) receptor in the
shell gland of the chicken oviduct and, recently, Hrabia et al.
(2013) have demonstrated the differential mRNA expression
and protein localization of GH receptors in the infundibulum,
magnum, isthmus and shell gland of laying hens and in the
vagina (unpublished data); these findings suggest that chicken
oviduct is also a GH-responsive organ. Moreover, hens
injected with exogenous GH show increased eggshell quality
of the eggs laid near the end of the laying period (Donoghue
et al. 1990).
Accumulating evidence in mammals indicates the involve-
ment of GH in the regulation of uterine function. Expression
of GH in the human uterus (Sbracia et al. 2004; Slater et al.
2006) and of GH receptor in human, mouse and bovine uterus
(Sharara et al. 1994; Kirby et al. 1996; Kölle et al. 2001;
Pershing et al. 2002; Sbracia et al. 2004; Rhoads et al. 2008)
has been demonstrated. The promotion of uterine growth by
GH and the involvement of the mitogenic action of GH in
uterine and cervical cancers have also been reported (Slater
et al. 2006; Pandey et al. 2008). In addition, GH has been
implicated in the regulation of implantation in mice (Zaczek
et al. 2002). However, the role of GH in the chicken oviduct is
unknown.
Therefore, in the present study, the effect of exogenous
chicken GH (cGH) on cell proliferation and apoptosis has
been examined in the domestic hen oviduct during sexual
maturation. Since numerous genes are involved in these
events and are thus potential targets of GH action, we have
determined the ability of GH to regulate the expression of anti-
apoptotic Bcl-2 protein and the activities of the most important
caspases involved in the various apoptotic pathways. As the
development of the oviduct is associated with differentiation
and specialization of cells of the particular oviductal segments
for the production of egg-specific proteins, the possibility that
GH regulates the synthesis of these proteins in the chicken
oviduct has also been evaluated. The following proteins have
been examined: ovalbumin, a protein that is synthesized main-
ly in the magnum and that constitutes 54 % of the egg white
(Nys et al. 2001), and the recently described eggshell-matrix
proteins produced predominantly in the shell gland (Gautron
et al. 2001, 2007; Hincke et al. 2003), i.e. ovocalyxin-32,
which influences the variability of crystal traits and, in turn,
the thickness profile of the shell (Takahashi et al. 2010; Dunn
et al. 2012; Fulton et al. 2012) and ovocalyxin-36, whose
expression is strongly upregulated during shell calcification
and which has antimicrobial activity and might play a role in




Recombinant cGH was prepared as described by Paczoska-
Eliasiewicz et al. (2006) and purchased from Protein
Laboratories Rehovot (Rehovot, Israel). The in situ cell-
death detection kit (POD–horseradish peroxidase) was from
Roche Diagnostics (Mannheim, Germany). The chemicals for
immunocytochemistry were obtained from the following
companies: mouse monoclonal antibody against proliferating
cell nuclear antigen (PCNA) from Novocastra Laboratories
(Newcastle upon Tyne, UK) and biotinylated goat antimouse
immunoglobulin, normal goat serum and Vectastain ABC kit
from Vector Laboratories (Burlingame, USA). The chemicals
for reverse transcription plus the polymerase chain reaction
(RT-PCR) were purchased from the following companies:
TRI-reagent from MRC, Cincinnati (Ohio, USA) and High-
Capacity cDNA Reverse Transcription Kit, TaqMan Gene
Expression Master Mix, TaqMan Gene Expression Assays
and Eukaryotic 18S rRNA Endogenous Control from
Applied Biosystems (Foster City, Calif., USA). Caspase fluo-
rometric assay kits were from BioVision (Milpitas, Calif.,
USA). All other reagents were obtained from ICN
Biomedicals (Aurora, Ill., USA), Sigma (St. Louis, Mo.,
USA) or POCH (Gliwice, Poland).
Animals and experimental design
Animal experiments were conducted according to research
protocols approved by the Local Animal Ethics Committee
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in Kraków, Poland. Immature Hy-Line brown chickens (layer
strain) were purchased at 9 weeks of age from the commercial
farm Drobeco (Palowice, Poland). Birds were caged individ-
ually under a photoperiod of 14 light:10 dark (lights on at
0700 h and off at 2100 h) with free access to commercial food
(11.5 MJ·kg-1, 15 % protein) and water. Ten-week-old pullets
(n=12) were divided equally into control and experimental
groups. Control birds were injected subcutaneously (abdom-
inal area) with 0.9 % (w/v) NaCl containing 0.05 % (w/v)
bovine serum albumin (BSA), and the experimental group
received recombinant cGH at a dose of 200 μg in 0.1 ml·kg-
1 body weight diluted in 0.9 % NaCl with 0.05 % BSA.
Injections were performed three times a week in the morning.
At the age of 16 weeks (about 1–2 weeks before puberty),
birds were decapitated and the oviducts were rapidly isolated.
After the oviducts had been weighed, four oviductal parts,
namely, the infundibulum, magnum, isthmus and shell gland,
were collected. Tissue samples were immediately frozen and
kept at –80 °C until the determination of caspase activity or
were placed into RNA later and stored at –20 °C until total
RNA isolation. The other tissue fragments were fixed in
freshly prepared 4 % (v/v) buffered formalin, processed and
embedded in paraffin wax for subsequent localization of pro-
liferating and apoptotic cells as described previously (Hrabia
et al. 2011).
Evaluation of proliferation by PCNA immunocytochemistry
After deparaffinization in xylene and rehydration in alcohols,
6-μm-thick sections were rinsed in water and treated with
0.5 % (v/v) H2O2 in methanol to block endogenous peroxi-
dase activity. After being washed in water, slides were heated
in a citric buffer (pH 6.0, 75 °C, 20 min) followed by incuba-
tion with 5 % (v/v) normal goat serum in TBST buffer (TRIS
buffer saline+0.1 % v/v Tween 20, at room temperature,
10 min). Sections were then incubated for 60 min with mouse
monoclonal antibody against PCNA, a marker of the S phase
of the cell cycle (dilution 1:150), followed by washes with
TBS and incubation with biotinylated goat antimouse anti-
body (35 min, dilution 1:300) and with Vectastain ABC kit
(30 min). The colour reaction was developed by incubation
with diaminobenzidine (DAB) and H2O2 solution. Control
slides were prepared by using TBST instead of the primary
antibody. Slides were examined under a light microscope
(Zeiss Jena, Germany). Proliferating (PCNA-positive) cells
were counted with a computerized image-analysis system
(MultiScanBase v. 14.02, Computer Scanning System,
Warsaw, Poland) in 10 random areas (50 × 50 μm) of each
examined magnum, isthmus and shell gland and averaged for
each bird. The mean value was calculated from six chickens.
The infundibulum was omitted in the cell-number calculation
as it was not possible accurately to measure the area of
mucosa.
Apoptosis evaluation by TUNEL assay
For the evaluation of apoptosis, deparaffinized and rehydrated
6-μm-thick sections of oviduct tissue were incubated with
proteinase K (20 μg·ml-1) in 10 mM TRIS-HCl, pH 7.4, at
37 °C for 20 min and apoptotic cells were detected by the
terminal deoxynucleotidyl transferase-mediated dUTP nick-
end labelling (TUNEL) method by using the in situ cell-death
detection kit POD according to the protocol provided by the
manufacturer (Roche). Negative controls were prepared by
incubating slides without terminal deoxynucleotidyl transfer-
ase. To visualize the immunoreaction products, sections were
incubated with a mixture of DAB and H2O2. Slides were
examined and TUNEL-positive cells were counted as for the
PCNA-positive cells.
RNA isolation, cDNA synthesis and quantitative PCR
Total RNA was extracted from the tissues by using TRI-
reagent according to manufacturer’s recommendations
(MRC). RNA (2 μg from each tissue) was reverse-
transcribed with a High-Capacity cDNA Reverse
Transcription Kit including random primers. Samples were
incubated in a thermocycler (Mastercycler Gradient;
Eppendorf, Hamburg, Germany) according to the following
thermal profile: 25 °C for 10min, 37 °C for 120min and 85 °C
for 5 min. The obtained cDNA was used in real-time PCR
for Bcl-2, caspases 2, 3, 8 and 9, ovalbumin and
ovocalyxins 32 and 36 in a 96-well thermocycler
(StepOne Plus; Applied Biosystems, USA) according to
the recommended cycling program: 2 min at 50 °C,
10 min at 95 °C, 40 cycles of 15 s at 95 °C and 60 s
at 60 °C. The multiplex real-time quantitative PCRs
(qPCRs) for the examined genes were performed in a
10 μl volume containing 5 μl TaqMan Gene Expression
Master Mix, 0.5 μl TaqMan Gene Expression Assays
with specific TaqMan MGB-probe and one pair of
primers designed by Applied Biosystems, 0.5 μl
Eucaryotic 18S rRNA Endogenous Control (pair of
primers and TaqMan probe-labelled VIC/TAMRA as a
reference gene), 3 μl water and 1 μl cDNA (ten-times-
diluted sample after the RT step). The TaqMan Gene
Expression Assay parameters are shown in Table 1.
Each sample was run in duplicate. A no-template control
was included in each run. Relative quantification of the
investigated genes was calculated after normalization
with the 18S rRNA transcript and by employing expres-
sion in the infundibulum of the control group as the
calibrator for Bcl-2 and caspases by using the 2-ΔΔCt
method. In the case of ovalbumin determined in the
magnum and ovocalyxins examined in the shell gland,
the control group was used as the cal ibra tor.
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Quantification was performed by using StepOne integrat-
ed software.
Caspase-activity assays
The enzymatic activity of caspases in the oviductal parts of
control and cGH-treated chickens was measured according to
Monroe et al. (2002) with ready-to-use fluorometric assay
kits. Briefly, tissue samples were homogenized in lysis buffer
(100 mg tissue per 300 μl buffer) and centrifuged.
Supernatants were collected and total protein concentrations
were determined by the Bradford method. A 100 μg aliquot of
protein from each sample or blank control was transferred in
duplicate to 96-well microplates. Immediately after a 2 h
incubation at 37 °C in reaction buffer with substrate, fluores-
cence at 400 nm excitation and 505 nm emission was read in a
Fluorescence Microplate Reader FLx800 (BioTek
Instruments, Winooski, Vt., USA). The activity of caspases
2, 3, 8 and 9 in the samples was normalized and expressed as
the percentage activity relative to the infundibulum of the
control group (set at 100 %).
Statistical analysis
For comparison of the means of the control and cGH-treated
groups, the Student t-test or Mann–Whitney Rank Sum test
was used. Differences were considered significant at P<0.05.
Calculations were performed with Sigma Stat 2.03 (Systat
Software). Data are presented as means ± SEM.
Results
The effects of cGH on body and oviduct weights are summa-
rized in Table 2. cGH had no effect on body weight, whereas
an increase (P<0.05) in oviduct weight and oviduct index
(oviduct weight/body weight × 100) was observed.
Immunocytochemical analysis of proliferating cells showed
their presence in all examined segments of the oviduct in
control and cGH-treated groups (Fig. 1a–h). Within the ovi-
ductal wall, the largest number of PCNA-positive cells was
observed in the mucosal epithelium; such cells were less
abundant in the mucosal tubular glands (note that, in the
infundibulum, the tubular glands were not developed) and
only a few were found in the stroma (muscle+connective
tissue). The numbers of proliferating cells per unit area
(50 μm × 50 μm) in the oviducts of control and experimental
groups are presented in Fig. 1i, j and follow the order mag-
num≥isthmus>shell gland for both the oviduct mucosa and
the stroma. GH treatment had no effect on proliferating cell
number. TUNEL-positive apoptotic cells were detected in the
oviduct parts of both examined groups (Fig. 2a–h). Within the
oviduct wall, the highest number of apoptotic cells was found
in the mucosal epithelium; such cells were less abundant in the
mucosal tubular glands and least abundant in the stroma. The
number of apoptotic cells per unit area (50 μm× 50μm) in the
mucosa and stroma of the control group did not differ
(P>0.05) among oviductal parts. Administration of cGH de-
creased the number of apoptotic cells in the mucosa of the
magnum (P<0.01), isthmus (P<0.001) and shell gland
(P<0.001), by 40 %, 42 % and 26.5 %, respectively, and in
the stroma of the isthmus (P<0.001) and shell gland
(P<0.001) by 54 % and 44 %, respectively (Fig. 2i, j).
The proliferation-to-apoptosis ratio in the mucosa of the
magnum, isthmus and shell gland was higher (P<0.001) by
93 %, 61 % and 52 %, respectively, in cGH-treated chickens
(Fig. 3a), whereas in the stroma, this ratio was elevated by
73 % and 107 % in the isthmus (P<0.001) and shell gland
(P<0.01), respectively, after cGH injections (Fig. 3b).
Table 1 TaqMan probe se-
quences and size of amplicons
generated by real-time polymer-
ase chain reaction assay for
chicken Bcl-2, caspases 2, 3, 8
and 9, ovalbumin and
ovocalyxins 32 and 36 in the
chicken oviduct
Gene Genbank accession number TaqMan probe (FAM5′→3′NFQ) Amplicon (bp)
Bcl-2 protein NM_205339.1 AAAGGCATCCCATCCTC 72
Caspase-2 NM_001167701.1 AAGCCTCCTGCAACTGT 97
Caspase-3 AF083029.1 CTGCTCCAGGCTACTACT 72
Caspase-8 NM_204592.2 CCGGCATTGTAGTTTC 88
Caspase-9 XM_424580.3 CAAAGCTCAGGAAATTG 51
Ovalbumin NM_205152.2 TCTGTCTGGCATCTCC 85
Ovocalyxin-32 AB547158.1 CCCGTGTGCTCTGTTG 79
Ovocalyxin-36 NM_001030861.1 CCCCAGAGAAAGCTTC 77
Table 2 Effect of chicken growth hormone (cGH) administration on
body weight, oviduct weight and oviduct index (means ± SEM from six
birds) in growing chickens; *P<0.05, different from control
Measured parameter Controla cGHa
Initial body weight (g) at age 10 weeks 876±26.3 866±23.8
Final body weight (g) at age 16 weeks 1502±22.5 1517±19.6
Oviduct weight (g) 6.34±1.54 18.65±6.86*
Oviduct index (%) 0.43±0.11 1.22±0.27*
a Treatments (three times a week) from 10 to 16 weeks of age
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The proliferation-related gene Bcl-2 showed the same level
of expression in all oviductal regions and was not changed by
cGH administration (data not shown). The mRNA expression
and activity of the apoptosis-related genes for caspases 2, 3, 8
and 9 in the infundibulum, magnum, isthmus and shell gland
of control and cGH-treated chickens are presented in Fig. 4a–
h. Lower (P<0.05) mRNA expression was found for caspase-
2 in the magnum (by 51 %) and for caspase-3 in the magnum
(by 58 %) and isthmus (by 55 %) of cGH-treated hens
(Fig. 4a, c). Administration of cGH caused a decrease
(P<0.05) in caspase-2 activity (by 30 %) and caspase-3 ac-
tivity (by 36 %) in the magnum (Fig. 4b, d).
The effect of cGH administration on selected oviduct-
specific gene expression is shown in Fig. 5. cGH stimulated
(P<0.05) ovalbumin mRNA expression in the magnum by
211 % and ovocalyxins 32 and 36 in the shell gland by 592 %
and 303 %, respectively.
Discussion
The present study demonstrates, for the first time, the effect of
recombinant cGH on chicken oviduct development and func-
tion. First, the effect of cGH administration on cell prolifera-
tion and apoptosis was examined in immature chickens. Both
proliferating (PCNA-positive) and apoptotic (TUNEL-
positive) cells were localized most frequently to the mucosa
and were less abundant in the stroma of the infundibulum,
magnum, isthmus and shell gland. This indicates that oviduct
growth and specialization before puberty are related to the
Fig. 1 Localization and number of proliferating (PCNA-positive) cells in
the chicken oviduct after chicken growth hormone (cGH) administration
before maturation (representative of 6 birds). a, c, e, g Localization of
proliferating cells (arrows) in the infundibulum, magnum, isthmus and
shell gland, respectively, of the control group. b, d, f, h Localization of
proliferating cells in the infundibulum, magnum, isthmus and shell gland,
respectively, of the cGH-treated birds. Numerous proliferating cells are
present in the mucosal epithelium (E) and tubular glands (TG). A lower
abundance of proliferating cells are localized in the stroma (S; connective
tissue+muscles). Note that proliferating cells occur at a similar frequency
in the oviductal segments of control and cGH-treated chickens. i, j
Number of proliferating cells in the mucosa (epithelium+tubular glands)
and stroma, respectively, of the magnum, isthmus and shell gland in
control and cGH-treated groups. Each value represents the mean ±
SEM. PCNA-positive cells counted on 10 randomly chosen fields
(50 μm x 50 μm) of each magnum, isthmus and shell gland were
averaged for each bird and for that microscopic field size and subsequent-
ly the mean value for six chickens was calculated
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mucosa, which shows the most dynamic development. The
similar localization and frequency of proliferating and apo-
ptotic cells clearly occurs because, in dynamically proliferat-
ing tissues, cells that are damaged or incorrect in some way
must be eliminated, usually by apoptotic pathways (Elmore
2007). No marked changes were observed in the number of
proliferating cells after cGH administration. In contrast, cGH
significantly decreased the number of apoptotic cells in the
mucosa and stroma of the oviductal parts examined 1–2 weeks
before predicted maturation. Thus, GH evidently has an anti-
apoptotic effect in the chicken oviduct before puberty, as
previously established in the chicken ovary (Hrabia et al.
2011) and in a wide range of mammalian reproductive
(Sirotkin and Makarevich 1999; Kölle et al. 2003; Sirotkin
2005; Pandey et al. 2008) and nonreproductive (for reviews,
see Sanders and Harvey 2008; Harvey 2010) tissue, including
immunological (Jeay et al. 2002; Luna et al. 2013), neural
(Shin et al. 2004; Alba-Betancourt et al. 2013) and retinal
(Sanders et al. 2005, 2009, 2011) tissues. Although an effect
of cGH on cell proliferation has not been detected in the
oviduct, cGH might act as a survival factor, since such an
effect has been observed in vitro in several avian cells, e.g. the
B-cells of the bursa of Fabricius (Rodríguez-Méndez et al.
2010) and retinal (Sanders et al. 2006) and cerebellar (Alba-
Betancourt et al. 2013) neurons.
As the balance between cell proliferation and apoptosis is
important for the proper development of various tissues, the
proliferation-to-apoptosis ratio has been determined in the
mucosa and stroma of the oviductal segments. Notably, al-
though a clear effect of cGH on proliferating cell number has
Fig. 2 Localization and number of apoptotic (TUNEL-positive) cells in
the chicken oviduct after cGH administration before maturation (repre-
sentative of 6 birds). a, c, e, g Localization of apoptotic cells (arrows) in
the infundibulum, magnum, isthmus and shell gland, respectively, of the
control group. b, d, f, h Localization of apoptotic cells in the infundibu-
lum, magnum, isthmus and shell gland, respectively, of the cGH-treated
birds. Many apoptotic cells are observed in the mucosal epithelium (E)
and tubular glands (TG). Fewer apoptotic cells are localized in the stroma
(S; connective tissue+muscles). Note that TUNEL-positive cells are less
abundant in the cGH-treated group than in the control group. i, j Number
of apoptotic cells in the mucosa (epithelium+tubular glands) and stroma,
respectively, of the magnum, isthmus and shell gland in control and cGH-
treated groups. Each value represents the mean ± SEM. **P<0.01,
***P<0.001 compared with control. TUNEL-positive cells counted on
10 randomly chosen fields (50 μm × 50 μm) of each magnum, isthmus
and shell gland were averaged for each bird and for that microscopic field
size and subsequently the mean value for six chickens was calculated
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not been found in the current investigation, the ratio of
proliferating-to-apoptotic cells in the oviductal wall is raised
by 52 % to 107 %; thus, cGH shifts the predominance of
apoptosis over proliferation and, as a consequence, signifi-
cantly increases (by 294%) the weight of the oviduct, whereas
the body weight is unchanged. A stronger action of GH has
been observed in the mucosa than in the stroma suggesting
that the mucosa, in which proliferation is crucial for oviduct
growth during maturation (Yu andMarquardt 1973), is mostly
susceptible to GH. This justifies the previous suggestion of
Hrabia et al. (2013) that GH plays a regulatory role in the
activity of the oviduct mucosa, since GH receptors in oviduc-
tal wall are localized predominantly in this tissue.
Previous studies have shown an anti-apoptotic effect of GH
overexpression, attributable at least in part to a decrease in the
expression of Bax, BAD and caspases 3, 8 and 9 and to an
increase in Bcl-2 production (Mitsunaka et al. 2001; Jeay et al.
2002; Arnold and Weigent 2004). To clarify the apoptotic
targets of GH in the chicken oviductal regions, the mRNA
expression of Bcl-2, the initiator caspases 2, 8 and 9 and the
executioner caspase-3 has been determined in the oviductal
segments after cGH administration. Bcl-2 mRNA expression
is not affected by cGH, as observed in chicken embryonic
neural retina (Harvey et al. 2006). Similarly, cGH does not
change the expression of the mRNA for survivin (another
proliferation-enhancing and anti-apoptotic protein) in the
hen oviduct (own unpublished data). Among the examined
caspases, the expression of caspase-2 mRNA in the magnum
and caspase-3 mRNA in the magnum and isthmus is reduced
by almost half in cGH-treated hens. The lack of an effect of
cGH on the mRNA expression of Bcl-2 and initiator caspases
8 and 9 in this work, as compared with the results of earlier
studies (Jeay et al. 2002; Shin et al. 2004; Alba-Betancourt
Fig. 3 Ratio of proliferating-to-apoptotic cells in the mucosa (a) and
stroma (b) of control and cGH-treated chickens before maturation. Each
value represents the mean ± SEM. **P<0.01, ***P<0.001 compared
with control
Fig. 4 Effect of cGH on caspase-2 (a, b), caspase-3 (c, d), caspase-8 (e, f)
and caspase-9 (g, h) gene expression and activity, respectively, in the
chicken oviduct before maturation. Each value in a, c, e and g represents
the mean of relative quantity (RQ) ± SEM from six chickens standardized
to control expression in the infundibulum. Each value in b, d, f and h
represents the mean of relative activity (%) ± SEM from six chickens
standardized to control activity, which was set at 100 %, in the infundib-
ulum. *P<0.05 compared with control
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et al. 2013), might be attributable to the experimental condi-
tions, namely the dose of cGH, the frequency of its adminis-
tration, the type of tissue or the physiological microenviron-
ment of the oviductal tissues. On the other hand, the specific
lowering of caspase-3 mRNA expression by cGH in the
magnum and isthmus indicates that the executioner caspase-
3 is a candidate gene target for GH regulation. This finding
extends that of Harvey et al. (2006) who have shown that
exogenous GH decreases the expression of caspase-3 in the
neural retina.
Since active caspases are required for cell apoptosis, the
activities of selected caspases (caspases 2, 8, 9 and 3) have
also been measured. We have found that, in the magnum of
cGH-treated chickens, caspase-2 and caspase-3 activity de-
creases. These data are in agreement with previous in vivo and
in vitro reports on birds in which GH reduced the activity of
caspase-3 in the retina (Harvey et al. 2006; Sanders et al.
2006), bursa of Fabricius (Luna et al. 2013) and cerebellum
(Alba-Betancourt et al. 2013). The present data provide addi-
tional evidence for the possible role of exogenous GH as an
anti-apoptotic factor in the chicken oviduct. The effect of GH
on caspase expression and activity, observed mainly in the
magnum, suggests that the mechanism of action of GH is cell-
and tissue-specific. Moreover, the activity of caspases is reg-
ulated by numerous molecules; hence, in the current study, the
observed inhibitory effect of cGH on caspase mRNA expres-
sion, which is not reflected in the attenuation of caspase
activity in the isthmus and shell gland, indicates that
additional factors are involved in the activation of the
examined caspases. Differential mechanisms of caspase
activation in particular sections of the oviduct require
additional evaluation.
The most interesting finding in this study is the remarkable
stimulation of ovalbumin and ovocalyxin mRNA expression
in the magnum and shell gland, respectively, by cGH. This
strongly indicates the participation of GH in the control of
chicken oviduct secretory activity and supports the proposal
of Donoghue et al. (1990) that GH is involved in eggshell
formation. The mentioned authors have also observed the
increased shell thickness of eggs laid by hens injected with
exogenous GH near the end of the egg-laying period.
Unfortunately, no ovocalyxin 32 or 36 antibodies are avail-
able, making it impossible to examine ovocalyxins at
the protein level. However, our current data provide
new insights for the development of strategies to im-
prove eggshell characteristics, since ovocalyxin-32 is a
candidate marker for eggshell traits in the development
of such strategies in commercial layer populations
(Takahashi et al. 2010).
The wide range of the physiological effects of GH, includ-
ing metabolism regulation, immune response, cell migration,
proliferation, prevention of cell death and gene transcription
(Pilecka et al. 2007; Sirotkin 2005; Harvey 2010), are the
results of its direct action via GH receptors localized in target
cells or of its indirect action via insulin-like growth factors
(IGFs). Thus, some actions of GH in chicken oviduct might be
mediated at least in part by IGFs. This suggestion is supported
by the finding that, in adult female chickens, exogenous GH
treatment markedly increases plasma concentrations of IGF-I
and IGF-binding proteins (Scanes et al. 1999). In primary
cultures of quail oviduct cells, an elevation of ovalbumin
synthesis by IGF-1 in cooperation with oestrogen has been
reported (Kida et al. 1995). GH might also induce oestrogen
receptors and, in this way, regulate chicken oviduct functions.
Of pertinence, a study has demonstrated the direct action of
GH on the rat liver leading to an increase oestrogen receptor
expression (Freyschuss et al. 1994). Furthermore, the involve-
ment of GH in the regulation of oestrogen sensitivity of the
vitellogenic response in the liver of male and female turtles
has also been revealed (Ho et al. 1982). Moreover, GH might
also exert its effect in the chicken oviduct through autocrine
and/or paracrine mechanisms, as has been strongly suggested
in other chicken reproductive tissues, i.e. in the ovary (Hrabia
et al. 2008, 2011, 2012; Ahumada-Solórzano et al. 2012) and
testis (Harvey et al. 2004; Luna et al. 2004; Martínez-Moreno
et al. 2011) in which GH is locally produced and exerts several
physiological effects. Although no information is yet available
as to whether GH is synthesized in the avian oviduct, this
possibility is highly likely.
In conclusion, taking into consideration the present results,
we suggest that GH, via the orchestration of apoptosis and the
expression of some oviduct-specific proteins, participates in
Fig. 5 Effect of cGH on gene
expression of ovalbumin (a) in
the magnum and ovocalyxin-32
(b) and ovocalyxin-36 (c) in the
shell gland of chickens before
maturation. Each value represents
the mean of relative quantity (RQ)
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the development and activity of the chicken oviduct prior to
the onset of egg laying.
Open AccessThis article is distributed under the terms of the Creative
Commons Attribution License which permits any use, distribution, and
reproduction in any medium, provided the original author(s) and the
source are credited.
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